Home
Products & Services
Support
About
Contact Us
FinancialContent is the trusted provider of stock market information to the media industry.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Biogen, Inc. (NQ: BIIB)
315.54 USD  -4.87 (-1.52%)
Official Closing Price  /  Updated: 7:57 PM EDT, Oct 22, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,736,200
Open 322.30
Bid (Size) 314.26 (1)
Ask (Size) 316.50 (1)
Prev. Close 320.41
Today's Range 314.16 - 323.85
52wk Range 249.17 - 388.67
Shares Outstanding 211,007,945
Dividend Yield N/A
Performance
YTD
-5.58%
-5.58%
1 Month
-9.07%
-9.07%
3 Month
-11.89%
-11.89%
6 Month
+21.69%
+21.69%
1 Year
-3.96%
-3.96%
Top News
More News
Biogen to Present Data from Alzheimer’s Disease Portfolio at the 2018 Clinical Trials on Alzheimer’s Disease (CTAD) Meeting
Biogen (Nasdaq: BIIB) announced it will present data from its Alzheimer’s disease (AD) clinical development portfolio at the upcoming Clinical Trials on Alzheimer’s Disease (CTAD) annual meeting in... Read More
from GlobeNewswire News Releases
IMRALDI™, Biogen’s Adalimumab Biosimilar Referencing Humira®, Is Launched in the European Union
Samsung Bioepis Co. Ltd, a joint venture between Samsung BioLogics and Biogen (Nasdaq: BIIB) today announced the European launch of IMRALDITM, an adalimumab biosimilar referencing Humira®.1 Read More
from GlobeNewswire News Releases
More News
Read More
Humira Copycats Launch In Europe As AbbVie Preps To Defend $6 Billion
from Investor's Business Daily
Biogen Q3 Earnings Outlook
category Market News , Earnings Previews , Earnings , and 3 more.
from Benzinga
Biogen and Samsung Bioepis Announce European Launch of IMRALDI™(adalimumab), Solidifying Leadership in European Anti-TNF Market
from Business Wire News Releases
These 2 Biotechs Poised To Top Quarterly Views Amid Slowdown
from Investor's Business Daily
Biogen earnings: It’s all about upcoming Alzheimer’s disease results
category SPX , BIIB , Analyst , and 14 more.
from MarketWatch
Noteworthy Friday Option Activity: BMY, HD, BIIB
category Stocks
from Market News Video
Lockheed Earnings On Tap As Saudi Deals Face Scrutiny: Investing Action Plan
from Investor's Business Daily
Next Support Level for Biogen Inc (BIIB) is $322.19
from Comtex SmarTrend® News Briefs
Better Buy: Biogen Inc. vs. Amgen Inc.
category NVS , BIIB , RHHBY , and 4 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
Financial Widgets

Display market data, financial news or stock quotes - Learn More

Advertising Network

Advertise on FinancialContent's huge network - Learn More

Web Services

Power your internet and wireless applications - Learn More

© Copyright FinancialContent Services, Inc.
Terms and Conditions Privacy Policy Contact Us twitter linkedin twitter

Contact Us

(888) 688-9880

Services

Financial Widgets Financial Pages Web Services Consulting Financial Calculations Stock Data for Excel Newspaper Services For Advertisers Monetization Services Content Syndication Press Release Syndication

Services by Industry

Online Media Financial Services Newspaper Investor Relations Financial Blog Corporate Intranets Digital Signage Television Android Developers iOS Developers Wire Services Radio

About Us

Overview Careers Management Team Latest News Newsletters

Support

Support Articles Report an issue